Antonio Morales-Hernández

Antonio Morales-Hernández

Auto-generated profile, based on publicly available information

Antonio Morales-Hernández

Department of Pathology and Laboratory Medicine, St. Jude Children’s Research Hospital, Memphis, TN, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
MWMegan Walker
Megan Walker
YLYichao Li
Yichao Li
AMAntonio Morales-Hernandez
Antonio Morales-Hernandez
QQQian Qi
Qian Qi
CPChaithanyarani Parupalli
Chaithanyarani Parupalli
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
The transcription factor (TF) nuclear factor I-X (NFIX) is a positive regulator of hematopoietic stem and progenitor cell (HSPC) transplantation. Nfix-deficient HSPCs exhibit a severe loss of repopulating activity, increased apoptosis, and a loss of colony-forming potential. However, the underlying mechanism remains elusive. Here, we performed cellular indexing of transcriptomes and epitopes by high-throughput sequencing (CITE-seq) on Nfix-deficient HSPCs and observed a loss of long-term hematopoietic stem cells and an accumulation of megakaryocyte and myelo-erythroid progenitors. The genome-wide binding profile of NFIX in primitive murine hematopoietic cells revealed its colocalization with other hematopoietic TFs, such as PU.1. We confirmed the physical interaction between NFIX and PU.1 and demonstrated that the 2 TFs co-occupy super-enhancers and regulate genes implicated in cellular respiration and hematopoietic differentiation. In addition, we provide evidence suggesting that the absence of NFIX negatively affects PU.1 binding at some genomic loci. Our data support a model in which NFIX collaborates with PU.1 at super-enhancers to promote the differentiation and homeostatic balance of hematopoietic progenitors.

1 September 2016 in NeuroToxicology
Verified
Journal Article
Closed access
AMAntonio Morales-Hernández
Antonio Morales-Hernández
MCMaría Corrales-Redondo
María Corrales-Redondo
JMJosé María Marcos Merino
José María Marcos Merino
FGFrancisco J. González-Rico
Francisco J. González-Rico
FSFrancisco J. Sánchez-Martín
Francisco J. Sánchez-Martín
JMJaime M. Merino
Jaime M. Merino

30 October 2024 in HemaSphere
Verified
Journal Article
Open access
AMAntonio Morales‐Hernández
Antonio Morales‐Hernández
EKEmilia Kooienga
Emilia Kooienga
HSHeather Sheppard
Heather Sheppard
GGGabriela Gheorghe
Gabriela Gheorghe
CCClaire Caprio
Claire Caprio
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
Gprasp1 and Gprasp2 encode proteins that control the stability and cellular trafficking of CXCR4, a master regulator of hematopoiesis whose dynamic regulation is required for appropriate trafficking of B‐cells in the germinal center (GC). Here, we report that Gprasp1 and Gprasp2‐deficient B‐cells accumulate in the GC and show transcriptional abnormalities, affecting the mechanisms controlling Aicda expression and exposing them to excessive somatic hypermutation. Consequently, about 30% of mice transplanted with Gprasp‐deficient hematopoietic stem and progenitor cells developed a biologically aggressive and fatal B‐cell hyperproliferative disease by 20–50 weeks posttransplant. Histological and molecular profiling reveal that Gprasp1‐ and Gprasp2‐deficient neoplasms morphologically resemble human high‐grade B‐cell lymphomas of germinal center origin with shared morphologic features of both Burkitt Lymphoma (BL) and diffuse large B‐cell lymphoma (DLBCL), and molecular features consistent with DLBCL, as well as elevated mutational burden and heterogenous transcriptional and mutational signature. Thus, reduced Gprasp1 and Gprasp2 gene expression perturbs B‐cell maturation and increases the risk of B‐cell neoplasms of germinal center origin. As this model recapitulates the essential features of the heterogenous group of human hematopoietic malignancies, it could be a powerful tool to interrogate the mechanisms of lymphomagenesis for these cancers.

9 May 2024 in Blood
Verified
Journal Article
Open access
PDF file
AMAntonio Morales-Hernández
Antonio Morales-Hernández
In this issue of Blood, Quaranta et al identify human circulating hematopoietic stem and progenitor cells (cHSPCs) that help maintain steady-state hematopo In this issue of Blood, Quaranta et al identify human circulating hematopoietic stem and progenitor cells (cHSPCs) that help maintain steady-state hematopo

11 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AHAlanna V. Van Huizen
Alanna V. Van Huizen
MZMattieu Zhai
Mattieu Zhai
HTHaruhito Totani
Haruhito Totani
DRDewmi Rathnayake
Dewmi Rathnayake
EKEmilia E. Kooienga
Emilia E. Kooienga
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
Endolysosomal trafficking supports cellular homeostasis through coordinated regulation of extrinsic signaling inputs. Hematopoietic stem cell (HSC) function requires a tightly regulated balance between quiescence for long-term preservation and rapid activation for blood production. Although lysosomal regulation of metabolism and quiescence has been linked to stem cell maintenance, the contribution of endocytic routing to lysosomal function remains incompletely understood. Here, we show that quiescent HSCs rely on elevated endocytosis to maintain self-renewal. This activity is mediated in part by GPRASP2, a post-endosomal sorting protein. HSCs enriched in GPRASP2 are functionally dormant yet molecularly primed for activation however, in response to proliferative cues, dormant HSCs exhibit reduced signaling and proliferation. Disruption of GPRASP2-mediated endocytosis induces rapid proliferation and increased expression of signaling constituents, consistent with a model in which elevated endocytosis attenuates signaling through receptor internalization. Thus, we identify endocytosis as a mechanism by which HSCs limit functional exhaustion arising from chronic activation.